Assay Detail
ADMET
CHEMBL1931135
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Cytotoxicity against human HEK293 cells after 2 days by alamar blue assay
14
Total Activities
14
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | ADMET |
| Organism | Homo sapiens |
| Cell Type | HEK293 |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Publication
Synthesis and antitumor activity of conjugates of 5-Fluorouracil and emodin.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 14 | 4.81 | 5.89 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL289277 | EMODIN | — | 1 | 5.89 |
| CHEMBL1927334 | — | — | 1 | 5.34 |
| CHEMBL1927338 | — | — | 1 | 4.53 |
| CHEMBL1927335 | — | — | 1 | 4.52 |
| CHEMBL185 | FLUOROURACIL | 4.0 | 1 | 4.37 |
| CHEMBL1927336 | — | — | 1 | 4.18 |
| CHEMBL1927327 | — | — | 1 | - |
| CHEMBL1927328 | — | — | 1 | - |
| CHEMBL1927329 | — | — | 1 | - |
| CHEMBL1927330 | — | — | 1 | - |
| CHEMBL1927331 | — | — | 1 | - |
| CHEMBL1927332 | — | — | 1 | - |
| CHEMBL1927333 | — | — | 1 | - |
| CHEMBL1927337 | — | — | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL289277 | EMODIN | IC50 | = | 1300.0 | nM | 5.89 |
| CHEMBL1927334 | — | IC50 | = | 4600.0 | nM | 5.34 |
| CHEMBL1927338 | — | IC50 | = | 29600.0 | nM | 4.53 |
| CHEMBL1927335 | — | IC50 | = | 30000.0 | nM | 4.52 |
| CHEMBL185 | FLUOROURACIL | IC50 | = | 42900.0 | nM | 4.37 |
| CHEMBL1927336 | — | IC50 | = | 66600.0 | nM | 4.18 |
| CHEMBL1927327 | — | IC50 | > | 100000.0 | nM | - |
| CHEMBL1927328 | — | IC50 | - | — | - | |
| CHEMBL1927329 | — | IC50 | - | — | - | |
| CHEMBL1927330 | — | IC50 | - | — | - | |
| CHEMBL1927331 | — | IC50 | - | — | - | |
| CHEMBL1927332 | — | IC50 | - | — | - | |
| CHEMBL1927333 | — | IC50 | > | 100000.0 | nM | - |
| CHEMBL1927337 | — | IC50 | > | 100000.0 | nM | - |